Skip to main content
Equibles

LOOMIS SAYLES & CO L P

Position in TARS — Tarsus Pharmaceuticals, Inc.

CIK 312348 BOSTON, MA
Back to TARS Full portfolio

Position in TARS

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$23,960,250
-$4,649,445 QoQ
Shares Held
380,684
-6.7% QoQ
Ownership
0.867%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#28
of 256 holders
Holding Since
Sep 2025
4 quarters on record
Voting authority Sole 98% Shared 0% None 2%

Common Shares in TARS Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

LOOMIS SAYLES & CO L P holds $4,120,076,195 across 24 Biotechnology names. TARS ranks #19 (0.6% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 3,920,953 $1,947,654,982
2 REGN
Regeneron Pharmaceuticals, Inc.
 1,859,172 $1,159,268,108
3 ALNY
Alnylam Pharmaceuticals, Inc.
 580,187 $174,653,692
4 LGND
Ligand Pharmaceuticals Inc
 291,805 $92,236,641
5 TWST
Twist Bioscience Corp
 861,309 $88,611,468
6 AXSM
Axsome Therapeutics, Inc.
 239,490 $58,619,966
7 VCEL
Vericel Corp
 1,200,239 $53,398,633
8 MIRM
Mirum Pharmaceuticals, Inc.
 443,636 $51,936,466

All Filings in TARS

Export CSV
4 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $23,960,250 380,684
2026-03-31 $28,609,695 407,836
2025-12-31 $36,180,560 441,873
2025-09-30 $23,171,815 389,901